UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury

European journal of pain, 2011-11, Vol.15 (10), p.1040-1048

2011

Volltextzugriff (PDF)

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody

Alzheimer's research & therapy, 2021-04, Vol.13 (1), p.80-14, Article 80

2021

Volltextzugriff (PDF)

Preliminary Analysis Of BAN2401 Effects On Brain Amyloid And ARIA-E Findings Over 12 Months Of Treatment In The Open-Label Extension Of The Phase2b Study BAN2401-G000-201 In Subjects With Early Alzheimer’s Disease (3006)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

Persistence Of BAN2401-Mediated Amyloid Reductions Post-treatment: A Preliminary Comparison of Amyloid Status Between the Core Phase of BAN2401-G000-201 and Baseline of the Open-Label Extension Phase in Subjects with Early Alzheimer’s Disease (1330)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

A preliminary account of ARIA‐E in the ongoing open‐label extension phase of BAN2401‐G000‐201 in subjects with early Alzheimer’s disease: Human/Human trials: Anti‐amyloid

Alzheimer's & dementia, 2020-12, Vol.16 (S9)

2020

Volltextzugriff (PDF)

A preliminary account of ARIA‐E in the ongoing open‐label extension phase of BAN2401‐G000‐201 in subjects with early Alzheimer’s disease

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

P2-455: The neurocognitive effects of donepezil on visual short-term memory capacity following 24 Hours of sleep deprivation

Alzheimer's & dementia, 2008-07, Vol.4 (4), p.T507-T508

2008

Volltextzugriff (PDF)

A preliminary assessment of longitudinal amyloid status in the ongoing open‐label extension phase in subjects with early Alzheimer’s disease: Human/Human trials: Anti‐amyloid

Alzheimer's & dementia, 2020-12, Vol.16 (S9)

2020

Volltextzugriff (PDF)

A preliminary assessment of longitudinal amyloid status in the ongoing open‐label extension phase in subjects with early Alzheimer’s disease

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease

Journal of Alzheimer's disease, 2010-01, Vol.22 (4), p.1241-1256

2010

Volltextzugriff (PDF)

[P1–056]: POPULATION PHARMACOKINETIC‐PHARMACODYNAMIC (PK/PD) MODELING OF E2027, A SELECTIVE PHOSPHODIESTERASE‐9 (PDE9) INHIBITOR, FOLLOWING SINGLE ASCENDING ORAL DOSES IN HEALTHY VOLUNTEERS

Alzheimer's & dementia, 2017-07, Vol.13 (7S_Part_5), p.P258-P258

2017

Volltextzugriff (PDF)

POPULATION PHARMACOKINETIC-PHARMACODYNAMIC (PK/PD) MODELING OF E2027, A SELECTIVE PHOSPHODIESTERASE-9 (PDE9) INHIBITOR, FOLLOWING SINGLE ASCENDING ORAL DOSES IN HEALTHY VOLUNTEERS

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P258-P258

2017

Volltextzugriff (PDF)

Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer's Disease

Biomolecules (Basel, Switzerland), 2016-04, Vol.6 (2), p.19-19

2016

Volltextzugriff (PDF)

PHASE 1 INVESTIGATION INTO THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF E2027, A SELECTIVE PHOSPHODIESTERASE-9 (PDE9) INHIBITOR

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P574-P575

2017

Volltextzugriff (PDF)

Evaluation of 11 C-GSK189254 as a Novel Radioligand for the H 3 Receptor in Humans Using PET

Journal of Nuclear Medicine, 2010-07, Vol.51 (7), p.1021-1029

2010

Volltextzugriff (PDF)

Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PET

The Journal of nuclear medicine (1978), 2010-07, Vol.51 (7), p.1021-1029

2010

Volltextzugriff (PDF)

Quantitative analysis of tau protein in paired helical filament preparations: Implications for the role of tau protein phosphorylation in PHF assembly in Alzheimer's disease

Neurobiology of aging, 1995-05, Vol.16 (3), p.409-417

1995

Volltextzugriff (PDF)

Examination of phosphorylated tau protein as a PHF-precursor at early stage alzheimer's disease

Neurobiology of aging, 1995-05, Vol.16 (3), p.433-445

1995

Volltextzugriff (PDF)

Authors' response to commentaries

Neurobiology of aging, 1995-05, Vol.16 (3), p.423-431

1995

Volltextzugriff (PDF)

Blocking cell division does not remove the requirement for Polycomb function in Drosophila embryogenesis

Development (Cambridge), 1990-12, Vol.110 (4), p.1319-1325

1990

Volltextzugriff (PDF)

Prevalence, Incidence, and Progression of Myopia of School Children in Hong Kong

Investigative ophthalmology & visual science, 2004-04, Vol.45 (4), p.1071-1075

2004

Volltextzugriff (PDF)

Antibody stabilization for thermally accelerated deep immunostaining

Nature methods, 2022-09, Vol.19 (9), p.1137-1146

2022

Volltextzugriff (PDF)

The Effect of Parental History of Myopia on Children's Eye Size and Growth: Results of a Longitudinal Study

Investigative ophthalmology & visual science, 2008-03, Vol.49 (3), p.873-876

2008

Volltextzugriff (PDF)

Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production

The Journal of pharmacology and experimental therapeutics, 2001-06, Vol.297 (3), p.915

2001

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Humans
(10)
Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Animals
(5)
Female
(5)
Aged
(4)
Alzheimer Disease - Metabolism
(4)
Alzheimer's Disease
(4)
Male
(4)
Neurosciences
(4)
Neurosciences & Neurology
(4)
Alzheimer Disease - Pathology
(3)
Biological And Medical Sciences
(3)
Brain - Metabolism
(3)
Medical Sciences
(3)
Middle Aged
(3)
Phosphorylation
(3)
Tau Protein
(3)
Adult
(2)
Alzheimer Disease - Diagnostic Imaging
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody

Preliminary Analysis Of BAN2401 Effects On Brain Amyloid And ARIA-E Findings Over 12 Months Of Treatment In The Open-Label Extension Of The Phase2b Study BAN2401-G000-201 In Subjects With Early Alzheimer’s Disease (3006)

Persistence Of BAN2401-Mediated Amyloid Reductions Post-treatment: A Preliminary Comparison of Amyloid Status Between the Core Phase of BAN2401-G000-201 and Baseline of the Open-Label Extension Phase in Subjects with Early Alzheimer’s Disease (1330)

A preliminary account of ARIA‐E in the ongoing open‐label extension phase of BAN2401‐G000‐201 in subjects with early Alzheimer’s disease: Human/Human trials: Anti‐amyloid

A preliminary account of ARIA‐E in the ongoing open‐label extension phase of BAN2401‐G000‐201 in subjects with early Alzheimer’s disease

P2-455: The neurocognitive effects of donepezil on visual short-term memory capacity following 24 Hours of sleep deprivation

A preliminary assessment of longitudinal amyloid status in the ongoing open‐label extension phase in subjects with early Alzheimer’s disease: Human/Human trials: Anti‐amyloid

A preliminary assessment of longitudinal amyloid status in the ongoing open‐label extension phase in subjects with early Alzheimer’s disease

A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease

[P1–056]: POPULATION PHARMACOKINETIC‐PHARMACODYNAMIC (PK/PD) MODELING OF E2027, A SELECTIVE PHOSPHODIESTERASE‐9 (PDE9) INHIBITOR, FOLLOWING SINGLE ASCENDING ORAL DOSES IN HEALTHY VOLUNTEERS

POPULATION PHARMACOKINETIC-PHARMACODYNAMIC (PK/PD) MODELING OF E2027, A SELECTIVE PHOSPHODIESTERASE-9 (PDE9) INHIBITOR, FOLLOWING SINGLE ASCENDING ORAL DOSES IN HEALTHY VOLUNTEERS

Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer's Disease

PHASE 1 INVESTIGATION INTO THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF E2027, A SELECTIVE PHOSPHODIESTERASE-9 (PDE9) INHIBITOR

Evaluation of 11 C-GSK189254 as a Novel Radioligand for the H 3 Receptor in Humans Using PET

Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PET

Quantitative analysis of tau protein in paired helical filament preparations: Implications for the role of tau protein phosphorylation in PHF assembly in Alzheimer's disease

Examination of phosphorylated tau protein as a PHF-precursor at early stage alzheimer's disease

Authors' response to commentaries

Blocking cell division does not remove the requirement for Polycomb function in Drosophila embryogenesis

Prevalence, Incidence, and Progression of Myopia of School Children in Hong Kong

Antibody stabilization for thermally accelerated deep immunostaining

The Effect of Parental History of Myopia on Children's Eye Size and Growth: Results of a Longitudinal Study

An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer's disease

Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production

Suchergebnisse filtern